2022-03-18 12:39:15
International Consensus Recommendations EGID Nomenclature
International consensus surrounding what subsets of eosinophilic gastrointestinal d ...
Find out More
2022-03-18 14:08:26
2022-02-08 09:10:56
Response to FDA denial of topical oral viscous formulation of budesonide
In December 2021, APFED reported that the U.S. Food and Drug Administration (FDA) denied the TAK-721 New Drug Application, indicating the drug – a budesonide ...
Find out More
2022-01-27 15:29:49
Action Needed on Medical Nutrition Equity Act
The Med ...
Find out More
2021-12-23 13:41:36
Industry News: Drug Development
FDA denies approval of TAK-721 (budesonide oral suspension) for EoE Takeda, the pharmaceutical company developing TAK-721 (budesonide oral sus ...
Find out More